Publication | Closed Access

Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK–CHOP signaling pathways

InflammationTumor BiologyMedicineApoptosisPharmacologyImmunologyCell DeathCancer BiologyAnti-cancer AgentRos-erk/p38 Mapk–chopCell Death MechanismsRadiation OncologyCell SignalingCancer ResearchTrail-induced Apoptosis